Variable recognition of Candida albicans strains by TLR4 and lectin recognition receptors

Medical Mycology

Volumn 48, Issue 7, 2010, Pages 897-903

  Netea, Mihai G ^a   Gow, Neil A R ^b   Joosten, Leo A B ^a   Verschueren, Ineke ^a   Van Der Meer, Jos W M ^a   Kullberg, Bart Jan ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

Candida albicans; Cytokines; Dectin 1; Lectin receptors; Mannose receptor; TLR4

Indexed keywords

DECTIN 1; MANNOSE RECEPTOR; MYELOID DIFFERENTIATION FACTOR 88; TOLL LIKE RECEPTOR 4;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANDIDA ALBICANS; CELL STRUCTURE; CELL WALL; CONTROLLED STUDY; FUNGAL CELL; FUNGAL STRAIN; FUNGUS IDENTIFICATION; HOST RESISTANCE; HOST SUSCEPTIBILITY; HUMAN; HUMAN CELL; IN VIVO STUDY; MOUSE; NONHUMAN; NORMAL HUMAN;

ANIMALS; CANDIDA ALBICANS; CANDIDIASIS; CARD SIGNALING ADAPTOR PROTEINS; HUMANS; IMMUNITY, INNATE; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NERVE TISSUE PROTEINS; RECEPTORS, MITOGEN; TOLL-LIKE RECEPTOR 4;

CANDIDA ALBICANS; MUS;

EID: 77957737142     PISSN: 13693786     EISSN: 14602709     Source Type: Journal    
DOI: 10.3109/13693781003621575     Document Type: Article

References (32)

1. Gudlaugsson O, Gillespie S, Lee K, et al. Attributable mortality of nosocomial candidemia, revisited. Clin Infect Dis 2003; 37: 1172-1177.
2. Wisplinghoff H, Bischoff T, Tallent SM, et al. Nosocomial blood-stream infections in US hospitals: analysis of 24, 179 cases from a prospective nationwide surveillance study. Clin Infect Dis 2004; 39: 309-317.
3. Netea MG, Van Tits LJH, Curfs JHAJ, et al. The increased suscepti-bility of TNFαLTα double knock-out mice to systemic candidiasis is due to defective recruitment and phagocytosis by neutrophils. J Immunol 1999; 163: 1498-1505.
4. Kaposzta R, Tree P, Marodi L, Gordon S. Characteristics of invasive candidiasis in gamma interferon-and interleukin-4-def cient mice: role of macrophages in host defense against Candida albicans. Infect Immun 1998; 66: 1708-1717.
5. Tonnetti L, Spaccapelo R, Cenci E, et al. Interleukin-4 and-10 exac-erbate candidiasis in mice. Eur J Immunol 1995; 25: 1559-1565.
6. Tada H, Nemoto E, Shimauki H, et al. Saccharomyces cerevisiae-and Candida albicans-derived mannan induced production of tumor necrosis factor alpha by human monocytes in a CD14-and Toll-like receptor 4-dependent manner. Microbiol Immunol 2002; 2002: 503-512.
7. Netea MG, de Graaf C, Vonk A, et al. The role of Toll-like receptors in the defense against disseminated candidiasis. J Infect Dis 2002; 185: 1483-1489.
8. Netea MG, Sutmuller R, Hermann C, et al. Toll-like receptor 2 inhibits cellular responses against Candida albicans through pathways medi-ated by IL-10 and CD4+CD25+ regulatory T cells. J Immunol 2004; 172: 3712-3718.
9. Bellocchio S, Montagnoli C, Bozza S, et al. The contribution of Toll-like/IL-1 receptor superfamily to innate and adaptive immunity to fungal pathogens in vivo. J Immunol 2004; 172: 3059-3069.
10. Netea MG, Gow NA, Munro CA, et al. Immune sensing of Candida albicans requires cooperative recognition of mannans and glucans by lectin and Toll-like receptors. J Clin Invest 2006; 116: 1642-1650.
11. Yamamoto Y, Klein TW, Friedman H. Involvement of mannose recep-tor in cytokine interleukin-1beta (IL-1beta), IL-6, and granulocyte-macrophage colony-stimulating factor responses, but not in chemokine macrophage inf ammatory protein 1beta (MIP-1beta), MIP-2, and KC responses, caused by attachment of Candida albicans to macrophages. Infect Immun 1997; 65: 1077-1082.
12. van de Veerdonk FL, Marijnissen RJ, Kullberg BJ, et al. The mac-rophage mannose receptor induces IL-17 in response to Candida albicans. Cell Host Microbe 2009; 5: 329-340.
13. Jouault T, Ibata-Ombetta S, Takeuchi O, et al. Candida albicans phos-pholipomannan is sensed through Toll-like receptors. J Infect Dis 2003; 188: 165-172.
14. Brown GD, Gordon S. A new receptor for beta-glucans. Nature 2001; 413: 36-37.
15. Brown GD, Herre J, Williams DL, et al. Dectin-1 mediates the biological effects of beta-glucans. J Exp Med 2003; 197: 1119-1124.
16. Gantner BN, Simmons RM, Canavera SJ, Akira S, Underhill DM. Collaborative induction of inf ammatory responses by dectin-1 and Toll-like receptor 2. J Exp Med 2003; 197: 1107-1117.
17. Gow NAR, Netea MG, Munro CA, et al. Recognition of Candida albicans b-glucan by dectin-1 induces cytokines and has non-redun-dant effects on the activation of innate immunity. J Infect Dis 2007; 196: 1565-1571.
18. Villamon E, Gozalbo D, Roig P, et al. Myeloid differentiation factor 88 (MyD88) is required for murine resistance to Candida albicans and is critically involved in Candida-induced production of cytokines. Eur Cytokine Netw 2004; 15: 263-271.
19. Villamon E, Gozalbo D, Roig P, et al. Toll-like receptor-2 is essential in murine defenses against Candida albicans infections. Microbes In-fect 2004; 6: 1-7
20. Taylor PR, Tsoni SV, Willment JA, et al. Dectin-1 is required for beta-glucan recognition and control of fungal infection. Nat Immunol 2007; 8: 31-38.
21. Murciano C, Villamon E, Gozalbo D, et al. Toll-like receptor 4 de-fective mice carrying point or null mutations do not show increased susceptibility to Candida albicans in a model of hematogenously disseminated infection. Med Mycol 2006; 44: 149-157.
22. Tavanti A, Davidson AD, Fordyce MJ, et al. Population structure and properties of Candida albicans, as determined by multilocus sequence typing. J Clin Microbiol 2005; 43: 5601-5613.
23. Lehrer RI, Cline MJ. Interaction of Candida albicans with human leu-kocytes and serum. J Bacterio 1969; 98: 996-1004.
24. Saijo S, Fujikado N, Furuta T, et al. Dectin-1 is required for host de-fense against Pneumocystis carinii but not against Candida albicans. Nat Immunol 2007; 8: 39-46.
25. van der Graaf CA, Netea MG, Verschueren I, van der Meer JW, Kullberg BJ. Differential cytokine production and Toll-like receptor signaling pathways by Candida albicans blastoconidia and hyphae. Infect Immun 2005; 73: 7458-7464.
26. Netea MG, Gow NA, Munro CA, et al. Immune sensing of Candida albicans requires cooperative recognition of mannans and glucans by lectin and Toll-like receptors. J Clin Invest 2006; 116: 1642-1650.
27. Popa C, Abdollahi-Roodsaz S, Joosten LA, et al. Bartonella quintana lipopolysaccharide is a natural antagonist of Toll-like receptor 4. In-fect Immun 2007; 75: 4831-4837.
28. Kullberg BJ, Van't Wout JW, Van Furth R. Role of granulocytes in enhanced host resistance to Candida albicans induced by recombinant interleukin-1. Infect Immun 1990; 58: 3319-3324.
29. von Bernuth H, Picard C, Jin Z, et al. Pyogenic bacterial infections in humans with MyD88 def ciency. Science 2008; 321: 691-696.
30. Plantinga TS, van der Velden WJFM, Ferwerda B, et al. Early stop codon polymorphism in human dectin-1 is associated with increased Candida colonisation in hematopoietic stem cell transplant patients. Clin Infect Dis 2009;49:724-32
31. Grimbacher B, Hennigs A, Nabavi M, et al. Chronic mucocutaneous candidiasis is associated with a homozygous mutation in CARD9. In: XIIIth Meeting of the European Society for Immunodef ciencies. Hertogenbosch, The Netherlands, 2008.
32. Van der Graaf CA, Netea MG, Morre SA, et al. Toll-like recep-tor 4 Asp299Gly/Thr399Ile polymorphisms are a risk factor for Candida bloodstream infection. Eur Cytokine Netw 2006; 17: 29-34.